{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:59:41Z","timestamp":1777348781626,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K08CA230155"],"award-info":[{"award-number":["K08CA230155"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013015","name":"Cedars-Sinai Medical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013015","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Guidelines endorse specific life expectancy (LE) cutoffs for consideration of definitive management of localized prostate cancer. Previous work has shown that patients prefer numeric, patient-specific LE estimates in consultations but that physicians often do not communicate LE in such detail. The persistent overtreatment of men with limited longevity despite these guidelines may in part be related to physician-mediated factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine physician barriers to the integration of LE in prostate cancer management, confidence in LE estimates, preferred method for LE calculation, and mode of LE communication in consultations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Structured interview study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Multidisciplinary cohort of 20 urologists, radiation oncologists, and medical oncologists who regularly counsel patients with prostate cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Approach<\/jats:title>\n                    <jats:p>Interviews were transcribed verbatim and coded using an open coding approach. Saliency analysis was used to describe emergent concepts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Results<\/jats:title>\n                    <jats:p>Physician-identified barriers to integration of LE in consultations included concerns about patient receptiveness (75%), the accuracy of LE prediction tools (50%), and lack of knowledge about how to effectively communicate LE (30%). There was significant heterogeneity in the sources of information used to calculate LE, with 85% using methods not incorporating a quantitative assessment of health status (55% gestalt method, 30% life tables). Most physicians had low (35%) or moderate (60%) confidence in LE predictions, which they cite as due to high variability in estimates (65%) and the need for further validation of predictive models (20%). To improve confidence in estimates, physicians wished for validated prediction tools (45%), incorporation of more variables (45%), reporting of the variability of LE estimates (30%), and molecular\/genetic biomarkers (25%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Addressing physician concerns about patient receptiveness, lack of knowledge about effective LE communication, and lack of confidence in LE predictions may be essential to reducing overtreatment of men with limited LE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11606-025-10062-2","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:56:57Z","timestamp":1769194617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Physician Preferences Regarding Integration of Life Expectancy in Prostate Cancer Management"],"prefix":"10.1007","author":[{"given":"John R.","family":"Heard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antwon","family":"Chaplin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Luu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry","family":"Khodyakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brennan","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Freedland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7540-3272","authenticated-orcid":false,"given":"Timothy J.","family":"Daskivich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"10062_CR1","doi-asserted-by":"crossref","unstructured":"Daskivich TJ, Fan KH, Koyama T, et al. Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med 2013;158(10):709\u201317.","DOI":"10.7326\/0003-4819-158-10-201305210-00005"},{"issue":"1","key":"10062_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cct.2008.08.002","volume":"30","author":"TJ Wilt","year":"2009","unstructured":"Wilt TJ, Brawer MK, Barry MJ, et al. The Prostate cancer Intervention Versus Observation Trial:VA\/NCI\/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer. Contemp Clin Trials 2009;30(1):81-7.","journal-title":"Contemp Clin Trials"},{"issue":"16","key":"10062_CR3","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1002\/cncr.28757","volume":"120","author":"TJ Daskivich","year":"2014","unstructured":"Daskivich TJ, Lai J, Dick AW, et al. Comparative effectiveness of aggressive versus nonaggressive treatment among men with early-stage prostate cancer and differing comorbid disease burdens at diagnosis. Cancer 2014;120(16):2432-9.","journal-title":"Cancer"},{"issue":"4","key":"10062_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/pcan.2010.33","volume":"13","author":"TJ Daskivich","year":"2010","unstructured":"Daskivich TJ, van de Poll-Franse LV, Kwan L, et al. From bad to worse: comorbidity severity and quality of life after treatment for early-stage prostate cancer. Prostate Cancer Prostatic Dis 2010;13(4):320-7.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10062_CR5","unstructured":"National Comprehensive Cancer Network: Prostate Cancer, Version 4.2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf."},{"issue":"1","key":"10062_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/JU.0000000000002757","volume":"208","author":"JA Eastham","year":"2022","unstructured":"Eastham JA, Auffenberg GB, Barocas DA, et al. Clinically Localized Prostate Cancer: AUA\/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management. Journal of Urology 2022;208(1):10-18.","journal-title":"Journal of Urology"},{"issue":"10","key":"10062_CR7","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1001\/jamasurg.2017.1586","volume":"152","author":"GB Auffenberg","year":"2017","unstructured":"Auffenberg GB, Lane BR, Linsell S, et al. Practice- vs Physician-Level Variation in Use of Active Surveillance for Men With Low-Risk Prostate Cancer. JAMA Surgery 2017;152(10):978.","journal-title":"JAMA Surgery"},{"issue":"1","key":"10062_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/jama.2015.6036","volume":"314","author":"MR Cooperberg","year":"2015","unstructured":"Cooperberg MR, Carroll PR. Trends in Management for Patients With Localized Prostate Cancer, 1990-2013. JAMA 2015;314(1):80.","journal-title":"JAMA"},{"issue":"21","key":"10062_CR9","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1001\/jama.2018.5616","volume":"319","author":"S Loeb","year":"2018","unstructured":"Loeb S, Byrne N, Makarov DV, et al. Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015. JAMA 2018;319(21):2231.","journal-title":"JAMA"},{"issue":"6","key":"10062_CR10","doi-asserted-by":"publisher","first-page":"e2112214","DOI":"10.1001\/jamanetworkopen.2021.12214","volume":"4","author":"K Vaculik","year":"2021","unstructured":"Vaculik K, Luu M, Howard LE, et al. Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs Cohort. JAMA Network Open 2021;4(6):e2112214-e2112214.","journal-title":"JAMA Network Open"},{"key":"10062_CR11","doi-asserted-by":"crossref","unstructured":"Daskivich T.J., Luu M., Heard J., et al. Overtreatment of Men with Prostate Cancer and Limited Longevity in the Active Surveillance Era. JAMA Intern Med 2024.","DOI":"10.1001\/jamainternmed.2024.5994"},{"issue":"1","key":"10062_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.eururo.2014.12.026","volume":"68","author":"O Bratt","year":"2015","unstructured":"Bratt O, Folkvaljon Y, Hjalm Eriksson M, et al. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer. Eur Urol 2015;68(1):53-8.","journal-title":"Eur Urol"},{"issue":"19","key":"10062_CR13","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1002\/cncr.28226","volume":"119","author":"TJ Daskivich","year":"2013","unstructured":"Daskivich TJ, Chamie K, Kwan L, et al. Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate cancer. Cancer 2013;119(19):3446-53.","journal-title":"Cancer"},{"issue":"11","key":"10062_CR14","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.6004\/jnccn.2018.7060","volume":"16","author":"DY Lichtensztajn","year":"2018","unstructured":"Lichtensztajn DY, Leppert JT, Brooks JD, et al. Undertreatment of High-Risk Localized Prostate Cancer in the California Latino Population. Journal of the National Comprehensive Cancer Network 2018;16(11):1353-1360.","journal-title":"Journal of the National Comprehensive Cancer Network"},{"issue":"1","key":"10062_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1001\/jamaoncol.2014.192","volume":"1","author":"K Chamie","year":"2015","unstructured":"Chamie K, Williams SB, Hu JC. Population-Based Assessment of Determining Treatments for Prostate Cancer. JAMA Oncology 2015;1(1):60.","journal-title":"JAMA Oncology"},{"issue":"1","key":"10062_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1186\/s12885-021-08386-3","volume":"21","author":"SD Ellis","year":"2021","unstructured":"Ellis SD, Hwang S, Morrow E, et al. Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists. BMC Cancer 2021;21(1):649.","journal-title":"BMC Cancer"},{"issue":"2","key":"10062_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/JU.0000000000002675","volume":"208","author":"TJ Daskivich","year":"2022","unstructured":"Daskivich TJ, Gale R, Luu M, et al. Variation in Communication of Competing Risks of Mortality in Prostate Cancer Treatment Consultations. J Urol 2022;208(2):301-308.","journal-title":"J Urol"},{"issue":"1","key":"10062_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jamasurg.2021.5803","volume":"157","author":"TJ Daskivich","year":"2022","unstructured":"Daskivich TJ, Gale R, Luu M, et al. Patient Preferences for Communication of Life Expectancy in Prostate Cancer Treatment Consultations. JAMA Surg 2022;157(1):70-72.","journal-title":"JAMA Surg"},{"issue":"9","key":"10062_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res 2005;15(9):1277-88.","journal-title":"Qual Health Res"},{"issue":"3","key":"10062_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023463","volume":"9","author":"G Rohde","year":"2019","unstructured":"Rohde G, S\u00f6derhamn U, Vistad I. Reflections on communication of disease prognosis and life expectancy by patients with colorectal cancer undergoing palliative care: a qualitative study. BMJ Open 2019;9(3):e023463.","journal-title":"BMJ Open"},{"issue":"9","key":"10062_CR21","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1200\/JCO.2004.04.095","volume":"22","author":"RG Hagerty","year":"2004","unstructured":"Hagerty RG, Butow PN, Ellis PA, et al. Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol 2004;22(9):1721-30.","journal-title":"J Clin Oncol"},{"issue":"6","key":"10062_CR22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1370\/afm.2309","volume":"16","author":"NL Schoenborn","year":"2018","unstructured":"Schoenborn NL, Janssen EM, Boyd C, et al. Older Adults\u2019 Preferences for Discussing Long-Term Life Expectancy: Results From a National Survey. The Annals of Family Medicine 2018;16(6):530-537.","journal-title":"The Annals of Family Medicine"},{"issue":"6","key":"10062_CR23","first-page":"521","volume":"24","author":"TJ Smith","year":"2010","unstructured":"Smith TJ, Dow LA, Virago E, et al. Giving honest information to patients with advanced cancer maintains hope. Oncology (Williston Park) 2010;24(6):521-5.","journal-title":"Oncology (Williston Park)"},{"issue":"1","key":"10062_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1001\/jamainternmed.2017.6871","volume":"178","author":"CE Pollack","year":"2018","unstructured":"Pollack CE, Radhakrishnan A, Parker AM, et al. Association Between Physicians\u2019 Experiences With Members of Their Social Network and Efforts to Reduce Breast Cancer Screening. JAMA Internal Medicine 2018;178(1):148.","journal-title":"JAMA Internal Medicine"},{"issue":"11","key":"10062_CR25","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1001\/jamainternmed.2022.4316","volume":"182","author":"NL Schoenborn","year":"2022","unstructured":"Schoenborn NL, Boyd CM, Pollack CE. Physician Attitudes About Using Life Expectancy to Inform Cancer Screening Cessation in Older Adults\u2014Results From a National Survey. JAMA Internal Medicine 2022;182(11):1229.","journal-title":"JAMA Internal Medicine"},{"issue":"5","key":"10062_CR26","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1001\/jamainternmed.2016.0670","volume":"176","author":"NL Schoenborn","year":"2016","unstructured":"Schoenborn NL, Bowman TL, 2nd, Cayea D, et al. Primary Care Practitioners' Views on Incorporating Long-term Prognosis in the Care of Older Adults. JAMA Intern Med 2016;176(5):671-8.","journal-title":"JAMA Intern Med"},{"key":"10062_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-024-08705-x","author":"L Kearney","year":"2024","unstructured":"Kearney L, Bolton RE, N\u00fa\u00f1ez ER, et al. Tackling Guideline Non-concordance: Primary Care Barriers to Incorporating Life Expectancy into Lung Cancer Screening Decision-Making\u2014A Qualitative Study. Journal of General Internal Medicine 2024; https:\/\/doi.org\/10.1007\/s11606-024-08705-x.","journal-title":"Journal of General Internal Medicine"},{"issue":"7233","key":"10062_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1136\/bmj.320.7233.469","volume":"320","author":"NA Christakis","year":"2000","unstructured":"Christakis NA. Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study Commentary: Why do doctors overestimate? Commentary: Prognoses should be based on proved indices not intuition. BMJ 2000;320(7233):469-473.","journal-title":"BMJ"},{"issue":"21","key":"10062_CR29","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1001\/archinte.158.21.2389","volume":"158","author":"NA Christakis","year":"1998","unstructured":"Christakis NA, Iwashyna TJ. Attitude and Self-reported Practice Regarding Prognostication in a National Sample of Internists. Archives of Internal Medicine 1998;158(21):2389.","journal-title":"Archives of Internal Medicine"},{"issue":"22","key":"10062_CR30","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1200\/JCO.2006.10.5411","volume":"25","author":"S Gripp","year":"2007","unstructured":"Gripp S, Moeller S, B\u00f6lke E, et al. Survival Prediction in Terminally Ill Cancer Patients by Clinical Estimates, Laboratory Tests, and Self-Rated Anxiety and Depression. Journal of Clinical Oncology 2007;25(22):3313-3320.","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10062_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.5489\/cuaj.11161","volume":"6","author":"KMYB Leung","year":"2012","unstructured":"Leung KMYB, Hopman WM, Kawakami J. Challenging the 10-year rule: The accuracy of patient life expectancy predictions by physicians in relation to prostate cancer management. Canadian Urological Association Journal 2012;6(5):367-373.","journal-title":"Canadian Urological Association Journal"},{"issue":"12","key":"10062_CR32","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1111\/jgs.15524","volume":"66","author":"JM More","year":"2018","unstructured":"More JM, Lang-Brown S, Romo RD, et al. \"Planting the Seed\": Perceived Benefits of and Strategies for Discussing Long-Term Prognosis with Older Adults. J Am Geriatr Soc 2018;66(12):2367-2371.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"10062_CR33","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jpainsymman.2018.01.017","volume":"55","author":"JM Thomas","year":"2018","unstructured":"Thomas JM, Fried TR. Defining the Scope of Prognosis: Primary Care Clinicians' Perspectives on Predicting the Future Health of Older Adults. Journal of Pain and Symptom Management 2018;55(5):1269-1275.e1.","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10062_CR34","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.juro.2016.08.096","volume":"197","author":"TJ Daskivich","year":"2017","unstructured":"Daskivich TJ, Wood LN, Skarecky D, et al. Limitations of the National Comprehensive Cancer Network((R)) (NCCN((R))) Guidelines for Prediction of Limited Life Expectancy in Men with Prostate Cancer. J Urol 2017;197(2):356-362.","journal-title":"J Urol"},{"issue":"3","key":"10062_CR35","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/JU.0000000000000287","volume":"202","author":"TJ Daskivich","year":"2019","unstructured":"Daskivich TJ, Thomas IC, Luu M, et al. External Validation of the Prostate Cancer Specific Comorbidity Index: A Claims Based Tool for the Prediction of Life Expectancy in Men with Prostate Cancer. J Urol 2019;202(3):518-524.","journal-title":"J Urol"},{"key":"10062_CR36","doi-asserted-by":"crossref","unstructured":"Kent M, Penson DF, Albertsen PC, et al. Successful external validation of a model to predict other cause mortality in localized prostate cancer. BMC Medicine 2016;14(1).","DOI":"10.1186\/s12916-016-0572-z"},{"key":"10062_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.urology.2021.05.056","volume":"155","author":"SJC Soerensen","year":"2021","unstructured":"Soerensen SJC, Thomas IC, Schmidt B, et al. Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration. Urology 2021;155:70-76.","journal-title":"Urology"},{"issue":"12","key":"10062_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240039","volume":"15","author":"DM Frendl","year":"2020","unstructured":"Frendl DM, Fitzgerald G, Epstein MM, et al. Predicting the 10-year risk of death from other causes in men with localized prostate cancer using patient-reported factors: Development of a tool. PLOS ONE 2020;15(12):e0240039.","journal-title":"PLOS ONE"},{"issue":"8","key":"10062_CR39","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/j.1532-5415.2011.03523.x","volume":"59","author":"MA Schonberg","year":"2011","unstructured":"Schonberg MA, Davis RB, McCarthy EP, et al. External Validation of an Index to Predict Up to 9\u2010Year Mortality of Community\u2010Dwelling Adults Aged 65 and Older. Journal of the American Geriatrics Society 2011;59(8):1444-1451.","journal-title":"Journal of the American Geriatrics Society"},{"issue":"10","key":"10062_CR40","doi-asserted-by":"publisher","first-page":"667","DOI":"10.7326\/0003-4819-159-10-201311190-00005","volume":"159","author":"H Cho","year":"2013","unstructured":"Cho H, Klabunde CN, Yabroff KR, et al. Comorbidity-Adjusted Life Expectancy: A New Tool to Inform Recommendations for Optimal Screening Strategies. Annals of Internal Medicine 2013;159(10):667.","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10062_CR41","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.eururo.2015.03.020","volume":"68","author":"JD Sammon","year":"2015","unstructured":"Sammon JD, Abdollah F, D\u2019Amico A, et al. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. European Urology 2015;68(5):756-765.","journal-title":"European Urology"},{"issue":"7","key":"10062_CR42","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1007\/s11606-020-05735-z","volume":"35","author":"MA Schonberg","year":"2020","unstructured":"Schonberg MA, Jacobson AR, Karamourtopoulos M, et al. Scripts and Strategies for Discussing Stopping Cancer Screening with Adults >\u200975\u00a0Years: a Qualitative Study. Journal of General Internal Medicine 2020;35(7):2076-2083.","journal-title":"Journal of General Internal Medicine"},{"key":"10062_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2024.04.012","author":"NA Friedrich","year":"2024","unstructured":"Friedrich NA, Luu M, Gale R, et al. Variation in content discussed by specialty in consultations for clinically localized prostate cancer. Urol Oncol 2024; https:\/\/doi.org\/10.1016\/j.urolonc.2024.04.012.","journal-title":"Urol Oncol"},{"key":"10062_CR44","doi-asserted-by":"crossref","unstructured":"Pruthi N, Spencer ES, Lyons M, et al. Feminization of the workforce in urologic oncology: Socioeconomic, workforce, and quality-of-life issues. Journal of Clinical Oncology 2015;33(7_suppl):72\u201372.","DOI":"10.1200\/jco.2015.33.7_suppl.72"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-10062-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-10062-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-10062-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:56:59Z","timestamp":1769194619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-10062-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":44,"alternative-id":["10062"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-10062-2","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Cedars-Sinai Medical Center institutional review board, study number: Pro#00053972.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors have no conflicts of interest to report that could influence or bias this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}